CPPCC members suggest establishing a national API base as soon as possible

Source: Guangming Daily, Nov 8, 2013 business news agency, Peng Zhao, Cao Yisun and Xiao Yanjun, members of the CPPCC Committee, put forward the proposal on establishing a national base of essential drugs and APIs for major diseases, which was greatly approved by the Ministry of industry and information technology and the Ministry of science and technology He said that he will increase support for Southwest China in the construction of Chinese herbal medicine base and technological transformation of Chinese patent medicine enterprises Abstract: Traditional Chinese medicine is an important part of the list of essential drugs Among the national essential drugs, 102 kinds of proprietary Chinese medicines involve 289 kinds of traditional Chinese medicines "Good medicine, good medicine." However, at present, the exploitation of wild medicinal resources is seriously "overdrawn", and the contradiction between supply and demand is increasingly prominent, which seriously threatens the foundation of sustainable development of traditional Chinese medicine in China According to the general survey, nearly 100 kinds of South medicine resources, such as aloe, Dracaena, Caulis Spatholobi, guangdougen, etc., have been exhausted, which not only makes the supply of basic drugs difficult in the relevant countries, but also causes the loss of the output value of thousands of varieties and tens of billions in the pharmaceutical industry The soaring price of traditional Chinese medicine affects the production and supply of drugs In 2010, 84% of 537 kinds of traditional Chinese medicine rose in price, with the highest increase over 300% The price of Chinese patent medicines listed in the catalogue of essential medicines is strictly limited Many Chinese patent medicines are estimated according to the actual dosage, and the price of raw materials has exceeded the price of Chinese patent medicines, resulting in the manufacturer's shutdown and affecting the supply of Chinese patent medicines The low level of innovation and industrialization will aggravate the loss of resources In recent years, drug planting in the international market has been ahead of China Facing the sharp increase of drug sales, developed countries have increased the research on traditional Chinese medicine, which poses a huge challenge to China's important industries in breeding, cultivation, planting, especially the research and application of extraction technology Therefore, it is suggested that a number of national bases for essential drugs and raw materials for major diseases should be established as soon as possible We will enhance the control of national medicinal resources and the international competitiveness of the Chinese medicine industry We will vigorously strengthen basic and applied research, comprehensively improve technological and industrial innovation capabilities, and comprehensively study the collection, conservation, reproduction, large-scale transplanting and ecological production of endangered medicinal animals and plants At the same time, scientific research institutions, universities and enterprises are encouraged to speed up the cultivation of innovative talents in science and technology of traditional Chinese medicine.